Source Capital is an insurance private equity investment management institution.
Source Capital is an insurance private equity investment management institution.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Feb 23, 2022
Guangzhou Baiyunshan Pharmaceutical Holdings
|
Post-IPO Equity | $1.43M | Manufacturing | Yes |
Feb 25, 2021
Moody
|
Series B | $39.25M | Beauty | — |
Jan 28, 2021
Moody
|
Series B | $19.64M | Beauty | — |
Jul 21, 2018
Yingsheng Biology
|
Series A | — | Biotechnology | — |
Nov 12, 2017
Frasergen
|
Series B | ¥50M | Bioinformatics | — |
Source Capital has had 2 exits. Source Capital most notable exits include Geneis , Guangzhou Baiyunshan Pharmaceutical Holdings
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
Jan 2, 2018 | Geneis | IPO | Health Care | Detail |
Feb 6, 2001 | Guangzhou Baiyunshan Pharmaceutical Holdings | IPO | Manufacturing | Detail |